Univar Inc. (UNVR) Lowered to Sell at Zacks Investment Research

Zacks Investment Research downgraded shares of Univar Inc. (NYSE:UNVR) from a hold rating to a sell rating in a research report report published on Tuesday morning.

According to Zacks, “Univar Inc. is a distributor of chemicals and innovative services. The Company offers solvents, resins, pigments, acids, bases, surfactants, glycols, inorganic compounds and alcohols. It also offers transportation and warehousing infrastructure, chemicals and hazardous materials handling services. The Company’s operating geographical segments include Univar USA, Univar Canada, Univar Europe and the Middle East as well as Rest of World. It serves coatings and adhesives, food, oil and gas, personal care and pharmaceutical industries. Univar Inc. is headquartered in Downers Grove, Illinois. “

UNVR has been the topic of a number of other reports. BidaskClub upgraded Univar from a sell rating to a hold rating in a report on Thursday, October 5th. Barclays PLC boosted their price target on Univar from $33.00 to $34.00 and gave the company an equal weight rating in a report on Monday, August 7th. Berenberg Bank assumed coverage on Univar in a report on Thursday, July 6th. They issued a sell rating and a $24.00 price target on the stock. Credit Suisse Group cut their price target on Univar from $39.00 to $36.00 and set an outperform rating on the stock in a report on Thursday, August 31st. Finally, Jefferies Group LLC restated a buy rating and issued a $39.00 price target on shares of Univar in a report on Friday, September 15th. Two analysts have rated the stock with a sell rating, two have issued a hold rating and four have given a buy rating to the company’s stock. The stock has a consensus rating of Hold and an average target price of $33.33.

Univar (NYSE UNVR) opened at 29.14 on Tuesday. Univar has a 12 month low of $20.54 and a 12 month high of $33.15. The firm’s market capitalization is $4.10 billion. The firm has a 50-day moving average price of $28.67 and a 200 day moving average price of $28.67.

Univar (NYSE:UNVR) last issued its quarterly earnings results on Friday, August 4th. The basic materials company reported $0.34 EPS for the quarter, beating analysts’ consensus estimates of $0.31 by $0.03. The company had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.27 billion. Univar had a positive return on equity of 15.46% and a negative net margin of 0.85%. The company’s quarterly revenue was down .7% compared to the same quarter last year. During the same period in the previous year, the company posted $0.29 earnings per share. On average, equities analysts forecast that Univar will post $0.90 EPS for the current year.

TRADEMARK VIOLATION NOTICE: “Univar Inc. (UNVR) Lowered to Sell at Zacks Investment Research” was first published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are accessing this news story on another site, it was copied illegally and reposted in violation of US & international copyright law. The original version of this news story can be accessed at https://ledgergazette.com/2017/10/11/univar-inc-unvr-lowered-to-sell-at-zacks-investment-research.html.

Several large investors have recently added to or reduced their stakes in UNVR. Great West Life Assurance Co. Can increased its position in shares of Univar by 40.2% in the first quarter. Great West Life Assurance Co. Can now owns 11,506 shares of the basic materials company’s stock valued at $352,000 after acquiring an additional 3,300 shares during the last quarter. Bank of New York Mellon Corp increased its position in shares of Univar by 17.1% in the first quarter. Bank of New York Mellon Corp now owns 212,768 shares of the basic materials company’s stock valued at $6,523,000 after acquiring an additional 31,068 shares during the last quarter. UBS Asset Management Americas Inc. increased its position in shares of Univar by 140.3% in the first quarter. UBS Asset Management Americas Inc. now owns 66,754 shares of the basic materials company’s stock valued at $2,047,000 after acquiring an additional 38,969 shares during the last quarter. Ameriprise Financial Inc. acquired a new stake in shares of Univar in the first quarter valued at about $4,517,000. Finally, Parametric Portfolio Associates LLC increased its position in shares of Univar by 56.1% in the first quarter. Parametric Portfolio Associates LLC now owns 135,210 shares of the basic materials company’s stock valued at $4,146,000 after acquiring an additional 48,598 shares during the last quarter. 96.65% of the stock is currently owned by institutional investors and hedge funds.

Univar Company Profile

Univar Inc is a distributor of commodity and specialty chemicals. The Company operates through four segments: Univar USA (USA); Univar Canada (Canada); Univar Europe and the Middle East and Africa (EMEA), and Rest of World. The Company’s USA segment

According to Zacks, “Univar Inc. is a distributor of chemicals and innovative services. The Company offers solvents, resins, pigments, acids, bases, surfactants, glycols, inorganic compounds and alcohols. It also offers transportation and warehousing infrastructure, chemicals and hazardous materials handling services. The Company’s operating geographical segments include Univar USA, Univar Canada, Univar Europe and the Middle East as well as Rest of World. It serves coatings and adhesives, food, oil and gas, personal care and pharmaceutical industries. Univar Inc. is headquartered in Downers Grove, Illinois. “

UNVR has been the topic of a number of other reports. BidaskClub upgraded Univar from a sell rating to a hold rating in a report on Thursday, October 5th. Barclays PLC boosted their price target on Univar from $33.00 to $34.00 and gave the company an equal weight rating in a report on Monday, August 7th. Berenberg Bank assumed coverage on Univar in a report on Thursday, July 6th. They issued a sell rating and a $24.00 price target on the stock. Credit Suisse Group cut their price target on Univar from $39.00 to $36.00 and set an outperform rating on the stock in a report on Thursday, August 31st. Finally, Jefferies Group LLC restated a buy rating and issued a $39.00 price target on shares of Univar in a report on Friday, September 15th. Two analysts have rated the stock with a sell rating, two have issued a hold rating and four have given a buy rating to the company’s stock. The stock has a consensus rating of Hold and an average target price of $33.33.

Univar (NYSE UNVR) opened at 29.14 on Tuesday. Univar has a 12 month low of $20.54 and a 12 month high of $33.15. The firm’s market capitalization is $4.10 billion. The firm has a 50-day moving average price of $28.67 and a 200 day moving average price of $28.67.

Univar (NYSE:UNVR) last issued its quarterly earnings results on Friday, August 4th. The basic materials company reported $0.34 EPS for the quarter, beating analysts’ consensus estimates of $0.31 by $0.03. The company had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.27 billion. Univar had a positive return on equity of 15.46% and a negative net margin of 0.85%. The company’s quarterly revenue was down .7% compared to the same quarter last year. During the same period in the previous year, the company posted $0.29 earnings per share. On average, equities analysts forecast that Univar will post $0.90 EPS for the current year.

TRADEMARK VIOLATION NOTICE: “Univar Inc. (UNVR) Lowered to Sell at Zacks Investment Research” was first published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are accessing this news story on another site, it was copied illegally and reposted in violation of US & international copyright law. The original version of this news story can be accessed at https://ledgergazette.com/2017/10/11/univar-inc-unvr-lowered-to-sell-at-zacks-investment-research.html.

Several large investors have recently added to or reduced their stakes in UNVR. Great West Life Assurance Co. Can increased its position in shares of Univar by 40.2% in the first quarter. Great West Life Assurance Co. Can now owns 11,506 shares of the basic materials company’s stock valued at $352,000 after acquiring an additional 3,300 shares during the last quarter. Bank of New York Mellon Corp increased its position in shares of Univar by 17.1% in the first quarter. Bank of New York Mellon Corp now owns 212,768 shares of the basic materials company’s stock valued at $6,523,000 after acquiring an additional 31,068 shares during the last quarter. UBS Asset Management Americas Inc. increased its position in shares of Univar by 140.3% in the first quarter. UBS Asset Management Americas Inc. now owns 66,754 shares of the basic materials company’s stock valued at $2,047,000 after acquiring an additional 38,969 shares during the last quarter. Ameriprise Financial Inc. acquired a new stake in shares of Univar in the first quarter valued at about $4,517,000. Finally, Parametric Portfolio Associates LLC increased its position in shares of Univar by 56.1% in the first quarter. Parametric Portfolio Associates LLC now owns 135,210 shares of the basic materials company’s stock valued at $4,146,000 after acquiring an additional 48,598 shares during the last quarter. 96.65% of the stock is currently owned by institutional investors and hedge funds.

Univar Company Profile

Univar Inc is a distributor of commodity and specialty chemicals. The Company operates through four segments: Univar USA (USA); Univar Canada (Canada); Univar Europe and the Middle East and Africa (EMEA), and Rest of World. The Company’s USA segment supplies a range of commodity and specialty chemicals, as well as services to a range of end markets, including manufacturing and industrial production sectors in the United States.

Analyst Recommendations for Univar (NYSE:UNVR)

Receive News & Ratings for Univar Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Univar Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply